Lung cancer care under the microscope: new study tracks Real-World outcomes
NCT ID NCT05872763
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This study follows 1,200 people in China who have just been diagnosed with advanced non-small-cell lung cancer (stage IIIB, IIIC, or IV) that cannot be removed by surgery. Researchers will collect information from medical records and follow participants over time to see what treatments they receive, how long they live, and what genetic markers their tumors have. The goal is to understand current medical practice and the real-world impact of the disease, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Chest Hospital
Beijing, 101149, China
-
Cancer Hospital Chinese Academy of Medical Sciences.
Beijing, 100021, China
-
First Affiliated Hospital of Medical College of Xi'an Jiaotong University
Xi'an, 710061, China
-
Guangxi Cancer Hospital of Guangxi Medical University
Nanning, 530021, China
-
Harbin Medical University Cancer Hospital
Harbin, 150081, China
-
Hubei Cancer Hospital
Wuhan, 430079, China
-
Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University)
Nanjing, 210029, China
-
Shandong Cancer Hospital
Jinan, 250117, China
-
Shanxi Province Cancer Hospital
Taiyuan, 030013, China
-
Sichuan Provincial Cancer Hospital
Chengdu, 610041, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, 450052, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, 050000, China
Conditions
Explore the condition pages connected to this study.